FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,276 letters match. Newest first.

  1. ImprimisRx NJ

    FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.

    High risk
  2. RemedyRepack, Inc.

    RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.

    High risk
  3. citypharma.us

    FDA warned citypharma.us for selling unapproved, misbranded opioid, benzodiazepine, and stimulant drugs to U.S. consumers online.

    High risk
  4. New England Life Care, Inc. dba Advanced Compounding Solutions

    FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.

    High risk
  5. Champaklal Maganlal Homeo Pharmacy Private Limited

    FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.

    High risk
  6. Sure-Biochem Laboratories, LLC

    FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.

    High risk
  7. iSlim, LLC

    FDA warned iSlim, LLC that its Alfia Weight Loss Capsules are an unapproved, misbranded drug containing undeclared sibutramine.

    High risk
  8. Pharmedica USA, LLC

    FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.

    High risk
  9. Sorcerz.com

    FDA warned Sorcerz.com for selling unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers online.

    High risk
  10. Drivergent, Inc.

    Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.

    High risk
  11. Premier Nutra Pharma Inc.

    FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.

    High risk
  12. Tager Online, Inc. DBA Volt Candy; Volt Candy Wholesale Club

    FDA warned Volt Candy that PrimeZEN Black 6000, sold as a supplement, contained undeclared tadalafil and sildenafil and was an unapproved, misbranded drug.

    High risk
  13. Nose Slap LLC

    FDA told Nose Slap LLC its NOSE SLAP and SOUL SLAP smelling-salt stimulants are unapproved and misbranded drugs.

    High risk
  14. Accra-Pac, Inc. dba Voyant Beauty

    Voyant Beauty's Elkhart, Indiana plant made OTC aerosol drugs contaminated with benzene and failed to investigate or test properly.

    High risk
  15. Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.

    FDA says Medolife sold unapproved Escozine drugs online with claims to treat cancer, HIV, and COVID-19.

    High risk
  16. Pharmaplast S.A.E.

    FDA cited Pharmaplast S.A.E. for failing to test drug components, including glycerin and ethanol, for dangerous contaminants.

    High risk
  17. Zermat International S.A. de C.V.

    FDA warns Zermat International about current good manufacturing practice violations for OTC drugs, including releasing out-of-specification lots without investigation.

    High risk
  18. Chemical Services Group, Inc./Royal Chemical Company

    Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.

    High risk
  19. Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy

    FDA warns Drug Depot dba APS Pharmacy over compounded drugs made with ineligible bulk substances.

    Medium
  20. Eco Lips, Inc.

    FDA warned Eco Lips, Inc. that its over-the-counter sunscreen drug products had serious manufacturing and testing failures.

    High risk
  21. Champaklal Maganlal Homeo Pharmacy Private Limited

    Champaklal Maganlal Homeo Pharmacy failed to test each glycerin lot for identity, including DEG/EG, in OTC and homeopathic drugs.

    High risk
  22. Omega Packaging Corp

    Omega Packaging Corp failed to test hand sanitizer ingredients and validate processes, FDA found.

    High risk
  23. Tyrone L. McCall, M.D./Cornea Associates of Texas

    FDA warns Dallas eye practice Cornea Associates for running a 69-subject drug study without an IND.

    High risk
  24. Robert J. Hayashi, M.D./Washington University School of Medicine, Department of Pediatrics

    FDA warned Dr. Robert J. Hayashi over protocol deviations in pediatric drug trials that exposed a child to unnecessary study drug and invasive procedures.

    High risk
  25. NuGeneration Technologies LLC

    FDA inspected NuGeneration Technologies' Emeryville, California drug plant and found CGMP failures in hand sanitizer release testing, ingredient and water testing, stability and process validation.

    High risk
  26. www.ivermectin4covid.com

    FDA warned website ivermectin4covid.com for selling unapproved, misbranded ivermectin drugs claiming COVID-19 use.

    High risk
  27. Procter & Gamble Manufactura S. de R.L. de C.V.

    FDA warned P&G Manufactura over mismatched active ingredients in the drug listing for Vicks Nyquil Severe Hot Remedy.

    Low
  28. Cosmetic Science Laboratories LLC

    FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.

    High risk
  29. Dunagin Pharmaceuticals Inc. dba Massco Dental

    Dunagin Pharmaceuticals dba Massco Dental made oral drugs with CGMP violations including shared equipment and inadequate component testing.

    High risk
  30. Maggie Jeffries, M.D. / Avanti Anesthesiology, LLC

    FDA warns Houston clinical investigator Dr. Maggie Jeffries for running drug trials without an IND and with informed-consent failures.

    High risk
  31. ElectRx and Health Solutions, LLC

    ElectRx causes introduction of unapproved and misbranded prescription drugs into interstate commerce by substituting foreign-sourced drugs for FDA-approved prescriptions.

    High risk
  32. Formology Lab Inc.

    FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.

    High risk
  33. Midlab Incorporated

    FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.

    High risk
  34. Frenda Corporation

    FDA found Frenda made OTC alcohol and hand sanitizer under insanitary conditions with industrial chemical cross-contamination risk.

    High risk
  35. Profounda, Inc.

    FDA warns Profounda about manufacturing quality failures for over-the-counter drugs, including process validation, stability, water system, and glycerin testing.

    High risk
  36. Atlantic Management Resources LTD dba. Claire Ellen Products

    Atlantic Management Resources (Claire Ellen Products) had CGMP violations and distributed unlisted Neuroquell Plus Cream.

    Medium
  37. B & J Group

    B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.

    High risk
  38. Gascó Industrial Corporation

    FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.

    High risk
  39. Skyless, LLC

    FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.

    High risk
  40. Ultra Chem Labs Corporation

    FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.

    High risk
  41. Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil

    FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.

    High risk
  42. Clean Cosmetics LLC

    FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.

    High risk
  43. The Body Bean, LLC

    FDA warns The Body Bean over unregistered, unlisted scented hand sanitizer for U.S. sale.

    Low
  44. Salon Technologies International, Inc.

    FDA warns Salon Technologies International that its hand sanitizers contained unacceptable acetaldehyde, acetal and benzene impurities and were adulterated.

    High risk
  45. Quality Supplement Manufacturing, Inc.

    FDA cited Quality Supplement Manufacturing for dietary supplement manufacturing and labeling violations, including undeclared shellfish allergens.

    High risk
  46. Noble Elements, LLC

    FDA warns Noble Elements over unapproved, misbranded Coated Silver drug claims on its website.

    High risk
  47. Organic Heirloom Plants

    FDA warned Organic Heirloom Plants over selling unapproved drugs with claims to treat mpox, cancer, diabetes and other diseases.

    High risk
  48. Dr. Green Mom, LLC

    FDA warned Dr. Green Mom, LLC that its vitamin, zinc, immunity and colloidal silver products are unapproved new drugs because of disease claims on its website.

    High risk
  49. Old Tiles Wallpaper, LLC DBA Old Tiles Decor

    Old Tiles Decor sold three unapproved 'Wind River' remedies online with drug claims, including treating mpox sores, heart problems and flu.

    High risk
  50. Monkeypox-treatment.com

    FDA warned Monkeypox-treatment.com and Eric Sminia for promoting Amazon-linked products as mpox treatments without FDA approval.

    High risk